Transurethral resection of the prostate achieves favorable outcomes in stroke patients with symptomatic benign prostate hyperplasia

References

• Verhamme KM, Dieleman JP, Bleumink GS, et al. Incidence and prevalence of lower urinary tract symptoms suggestive of benign prostatic hyperplasia in primary care – the Triumph project. Eur Urol. 2002;42:323–328.
   PubMed Web of Science ®Google Scholar
• Guess HA, Arrighi HM, Metter EJ, et al. Cumulative prevalence of prostatism matches the autopsy prevalence of benign prostatic hyperplasia. Prostate. 1990;17:241–246.
   PubMed Web of Science ®Google Scholar
• Saigal CS, Joyce G. Economic costs of benign prostatic hyperplasia in the private sector. J Urol. 2005;173:1309–1313.
   PubMed Web of Science ®Google Scholar
• Irwin DE, Kopp ZS, Agatep B, et al. Worldwide prevalence estimates of lower urinary tract symptoms, overactive bladder, urinary incontinence and bladder outlet obstruction. BJU Int. 2011;108:1132–1138.
   PubMed Web of Science ®Google Scholar
• Litman HJ, McKinlay JB. The future magnitude of urological symptoms in the USA: projections using the Boston Area Community Health survey. BJU Int. 2007;100:820–825.
   PubMed Web of Science ®Google Scholar
• Li Y, Zhang C, Wu Y, et al. Global burden of stroke in 2010: a pooling analysis of worldwide population-based data on stroke incidence. J Public Health. 2016;24:513–520.
   Google Scholar
• Marinkovic SP, Badlani G. Voiding and sexual dysfunction after cerebrovascular accidents. J Urol. 2001;165:359–370.
   PubMed Web of Science ®Google Scholar
• Brittain KR, Perry SI, Peet SM, et al. Prevalence and impact of urinary symptoms among community-dwelling stroke survivors. Stroke. 2000;31:886–891.
   PubMed Web of Science ®Google Scholar
• Burney TL, Senapati M, Desai S, et al. Acute cerebrovascular accident and lower urinary tract dysfunction: a prospective correlation of the site of brain injury with urodynamic findings. J Urol. 1996;156:1748–1750.
   PubMed Web of Science ®Google Scholar
• Meng NH, Lo SF, Chou LW, et al. Incomplete bladder emptying in patients with stroke: is detrusor external sphincter dyssynergia a potential cause? Arch Phys Med Rehabil. 2010;91:1105–1109.
   PubMed Web of Science ®Google Scholar
• Corona G, Vignozzi L, Rastrelli G, et al. Benign prostatic hyperplasia: a new metabolic disease of the aging male and its correlation with sexual dysfunctions. Int J Endocrinol. 2014;2014. Available from: http://dx.doi.org/10.1155/2014/329456
   Web of Science ®Google Scholar
• Lin KH, Lin YW, Wen YC, et al. Efficacy and safety of orally disintegrating tamsulosin tablets in Taiwanese patients with benign prostatic hyperplasia. Aging Male. 2012;15:246–252.
   PubMed Web of Science ®Google Scholar
• Kim EH, Larson JA, Andriole GL. Management of benign prostatic hyperplasia. Annu Rev Med. 2016;67:137–151.
   PubMed Web of Science ®Google Scholar
• Hsiao F, Yang C, Huang Y, et al. Using Taiwan’s national health insurance research databases for pharmacoepidemiology research. J Food Drug Anal. 2007;15.2:99.
   Web of Science ®Google Scholar
• Rassweiler J, Teber D, Kuntz R, et al. Complications of transurethral resection of the prostate (TURP)-incidence, management, and prevention. Eur Urol. 2006;50:969–980.
   PubMed Web of Science ®Google Scholar
• Larouche A, Becker A, Schiffmann J, et al. Comparison between complication rates of laser prostatectomy electrocautery transurethral resection of the prostate: a population-based study. CUAJ. 2014;8:E419–E424.
   Google Scholar
• Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004;240:205–213.
   PubMed Web of Science ®Google Scholar
• Uchida T, Ohori M, Soh S, et al. Factors influencing morbidity in patients undergoing transurethral resection of the prostate. Urology. 1999;53:98–104.
   PubMed Web of Science ®Google Scholar
• Thomas LH, Barrett J, Cross S, et al. Prevention and treatment of urinary incontinence after stroke in adults. Cochrane Library. 2005;Jul 20;(3):CD004462.
   PubMed Web of Science ®Google Scholar
• Kong KH, Young S. Incidence and outcome of poststroke urinary retention: a prospective study. Arch Phys Med Rehabil. 2000;81:1464–1467.
   PubMed Web of Science ®Google Scholar
• Linsenmeyer TAZRD. Urodynamic findings in patients with urinary incontinence after cerebrovascular accident. NeuroRehabilitation. 1992;2:23–26.
   Google Scholar
• Han KS, Heo SH, Lee SJ, et al. Comparison of urodynamics between ischemic and hemorrhagic stroke patients; can we suggest the category of urinary dysfunction in patients with cerebrovascular accident according to type of stroke? Neurourol Urodyn. 2010;29:387–390.
   PubMed Web of Science ®Google Scholar
• Gelber DA, Good DC, Laven LJ, et al. Causes of urinary incontinence after acute hemispheric stroke. Stroke. 1993;24:378–382.
   PubMed Web of Science ®Google Scholar
• Ma VY, Chan L, Carruthers KJ. Incidence, prevalence, costs, and impact on disability of common conditions requiring rehabilitation in the United States: stroke, spinal cord injury, traumatic brain injury, multiple sclerosis, osteoarthritis, rheumatoid arthritis, limb loss, and back pain. Arch Phys Med Rehabil. 2014;95:986–995.
   PubMed Web of Science ®Google Scholar
• Olesen J, Gustavsson A, Svensson M, et al. The economic cost of brain disorders in Europe. Eur J Neurol. 2012;19:155–162.
   PubMed Web of Science ®Google Scholar
• Chen CM, Ke YL. Predictors for total medical costs for acute hemorrhagic stroke patients transferred to the rehabilitation ward at a regional hospital in Taiwan. Top Stroke Rehabil. 2016;23:59–66.
   PubMed Web of Science ®Google Scholar
• Coban S, Doluoglu OG, Keles I, et al. Age and total and free prostate-specific antigen levels for predicting prostate volume in patients with benign prostatic hyperplasia. Aging Male. 2016;19:124–127.
   PubMed Web of Science ®Google Scholar
• Ferreira FT, Daltoé L, Succi G, et al. Relation between glycemic levels and low tract urinary symptoms in elderly. Aging Male. 2015;18:34–37.
   PubMed Web of Science ®Google Scholar
• Kaplan SA, Lee JY, O’Neill EA, et al. Prevalence of low testosterone and its relationship to body mass index in older men with lower urinary tract symptoms associated with benign prostatic hyperplasia. Aging Male. 2013;16:169–172.
   PubMed Web of Science ®Google Scholar
• Ko WJ, Han HH, Ham WS, et al. Daily use of sildenafil 50 mg at night effectively ameliorates nocturia in patients with lower urinary tract symptoms associated with benign prostatic hyperplasia: an exploratory multicenter, double-blind, randomized, placebo-controlled study. Aging Male. 2017;20:81–88.
   PubMed Web of Science ®Google Scholar
• Favilla V, Russo GI, Privitera S, et al. Impact of combination therapy 5-alpha reductase inhibitors (5-ARI) plus alpha-blockers (AB) on erectile dysfunction and decrease of libido in patients with LUTS/BPH: a systematic review with meta-analysis. Aging Male. 2016;19:175–181.
   PubMed Web of Science ®Google Scholar
• Qian X, Liu H, Xu D, et al. Functional outcomes and complications following B-TURP versus HoLEP for the treatment of benign prostatic hyperplasia: a review of the literature and Meta-analysis. Aging Male. 2017;3:1–8.
   Web of Science ®Google Scholar
• Allen S, Aghajanyan I. Use of thermobalancing therapy in ageing male with benign prostatic hyperplasia with a focus on etiology and pathophysiology. Aging Male. 2017;20:28–32.
   PubMed Web of Science ®Google Scholar